Results 241 to 250 of about 1,454,464 (291)
Some of the next articles are maybe not open access.
Best Practice & Research Clinical Rheumatology, 1999
Some severe auto-immune diseases, including rheumatoid arthritis, require immunosuppression to save life or vital organ function. One major limiting factor in such immunosuppression is the unwanted and dangerous haematoablation occurring at the same time.
A, Tyndall, S, Millikan
openaire +5 more sources
Some severe auto-immune diseases, including rheumatoid arthritis, require immunosuppression to save life or vital organ function. One major limiting factor in such immunosuppression is the unwanted and dangerous haematoablation occurring at the same time.
A, Tyndall, S, Millikan
openaire +5 more sources
The Indian Journal of Pediatrics, 1993
Bone marrow transplantations have a definite role in treatment of leukemias and lymphomas. In acute myeloid leukemia and CML an allogeneic transplant using an HLA identical donor certainly provides a far superior survival than chemotherapy. Patients with Ph' chromosome need to be transplanted in first remission if a suitable donor is available.
openaire +2 more sources
Bone marrow transplantations have a definite role in treatment of leukemias and lymphomas. In acute myeloid leukemia and CML an allogeneic transplant using an HLA identical donor certainly provides a far superior survival than chemotherapy. Patients with Ph' chromosome need to be transplanted in first remission if a suitable donor is available.
openaire +2 more sources
Transplantation of Chimeric Bone Marrow
International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1961SummaryRetransplantation of bone marrow was studied in an attempt to understand why foetal liver was superior to adult bone marrow in the treatment of lethally-irradiated mice.Presensitization experiments, in which recipients were immunized against cells of the future donor-strain, were performed.
Vos, O, Goodman, J W, Congdon, C C
openaire +3 more sources
BONE MARROW TRANSPLANTATION IN THALASSEMIA
Annual Review of Medicine, 1995▪ Abstract Early trials of allogeneic bone marrow transplantation (BMT) for homozygous β-thalassemia and the analyses of results of transplantation in patients less than 16 years old have allowed us to identify three classes of risk based on the following criteria: (a) hepatomegaly, (b) presence of liver fibrosis at histological examination, and (c ...
G, Lucarelli, C, Giardini, E, Angelucci
openaire +4 more sources
Bone Marrow Purging for Autologous Bone Marrow Transplantation
Leukemia & Lymphoma, 1993High dose therapy with the resulting myeloablation rescued by infusion of autologous bone marrow (ABMT) has become a major treatment option for an increasing number of patients with hematologic and solid tumors. ABMT has several potential advantages over allogeneic transplantation.
J G, Gribben, L M, Nadler
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 1985
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
Allogeneic bone marrow transplantation
Seminars in Oncology Nursing, 1994From highly investigational to standardized therapy, allogeneic BMT has established its role in the treatment of selected diseases. Continued refinements in bone marrow transplantation will increase the number of potential candidates, reduce associated risks, and improve disease-free survival rates.
T, Franco, D A, Gould
openaire +2 more sources
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1987
Since the 1970s major progress in bone marrow transplantation has resulted in long‐term survival and even cure for many patients with serious hematologic disease. Many patients undergoing the procedure, however, experience serious complications, including graft rejection, graft‐versus‐host disease, and infection.
openaire +2 more sources
Since the 1970s major progress in bone marrow transplantation has resulted in long‐term survival and even cure for many patients with serious hematologic disease. Many patients undergoing the procedure, however, experience serious complications, including graft rejection, graft‐versus‐host disease, and infection.
openaire +2 more sources
Sinusitis in Bone Marrow Transplantation
Southern Medical Journal, 1994Bone marrow transplantation has become a beneficial and curative technique used in treatment of patients with different hematologic conditions. It has become widely used at our institution for hematologic malignancies and certain resistant solid tumors. However, this treatment can result in immunosuppression, with an increased chance of infection.
S, Yee +3 more
openaire +2 more sources
The pathology of bone marrow transplantation
Histopathology, 1993The pathological complications of bone marrow transplantation are complex and may affect any organ in the body. The causes are often multifactorial and include the effects of chemotherapy, the conditioning regimen, drugs used in the post‐transplant period such as immunosuppressants and antibiotics, graft‐versus‐host disease (GvHD) and the effects of ...
J P, Sloane, J, Norton
openaire +2 more sources